Adma Biologics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Ramsey, NJ
ADMA chart
What traders are saying about $ADMA
Latest postsAdma Biologics, Inc. news
- Avoiding Lag: Real-Time Signals in (ADMA) Movement
Stock Traders Daily ·
- ADMA Biologics Inc Estimates – NASDAQ:ADMA
TradingView ·
- ADMA Biologics Slips 0.54% to $10.95 as Shares Press Toward Support Near $10.40 - Double EMA
https://www.siam.in/ ·
- ADMA Biologics Inc (ADMA) Stock Forecasts
Yahoo Finance ·
- Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
Yahoo Finance ·
- How Investors May Respond To ADMA Biologics (ADMA) Peer‑Reviewed Validation Of IVIG Safety And Purity
Yahoo Finance ·
- ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
Yahoo Finance ·
- Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
Yahoo Finance ·
- Intellia Therapeutics (NTLA) Soars 7.6%: Is Further Upside Left in the Stock?
Yahoo Finance ·
- Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
Yahoo Finance ·
- ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance ·
- Here's Why Adma Biologics (ADMA) Fell More Than Broader Market
Yahoo Finance ·
Adma Biologics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $510.2M | $426.5M | $258.2M | $154.1M |
| Net income | $146.9M | $197.7M | -$28.2M | -$65.9M |
| Diluted EPS | $0.60 | $0.81 | $-0.13 | $-0.33 |
| Total assets (year end) | $624.2M | $488.7M | $329.2M | $348.5M |
| Cash and equivalents (year end) | $87.6M | $103.1M | $51.4M | $86.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Adma Biologics, Inc.
- Ticker
- ADMA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Ramsey, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1368514
- Former names
- R&R ACQUISITION VI, INC
Frequently asked questions
What exchange is Adma Biologics, Inc. listed on?
Adma Biologics, Inc. trades on the Nasdaq under the ticker symbol ADMA.
What industry is Adma Biologics, Inc. in?
Adma Biologics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Adma Biologics, Inc. headquartered?
Adma Biologics, Inc.'s business address on file with the SEC is in Ramsey, NJ.
When does Adma Biologics, Inc.'s fiscal year end?
Adma Biologics, Inc.'s fiscal year ends on December 31.
How much revenue did Adma Biologics, Inc. report?
Adma Biologics, Inc. reported $510.2M in revenue for calendar year 2025, according to its SEC filings.